|Description||This active molecular is high affinity nonselective melatonin receptors MT1 and MT2 agonist which is under development for the treatment of insomnia and other sleep disorders. Its agonist action on MT1 and MT2 receptors in the suprachiasmatic nucleus in the brain enables its action as a chronobiotic. The action of LY 156735 on MT1 and MT2 receptors promots sleeping because melatonin's effects at these same receptors is linked with maintenance of normal-sleep wake cycle. The EC50 value of LY 156735 is 0.0479nM, compared to 0.063nM for melatonin. In May 2004, LY 156735 had received orphan drug status for the treatment of circadian sleep disorders in totally blind individuals in the US. In Nov 2005, data which was presented at the 18th Annual Congress of the European College of Neuropsychopharmacology had been added to the adverse events and Anxiety disorders therapeutic trials sections.|
|Synonyms||LY 156735; LY156735; LY-156735; TIK-301; TIK 301; TIK301; N-[(2R)-2-(6-chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide,|
|Solubility||Soluble in DMSO|
|Application||the treatment of insomnia and other sleep disorders|
|Quality Standard||In-house standard|
|Shelf Life||2 month in rt, long time|
|Current Developer||Tikvah Therapeutics|
AH 001 is a potent melatonin agonist.
Tasimelteon (trade name Hetlioz) is a drug approved by the FDA solely for the treatment of non-24-hour sleep–wake disorder (often designated as N24HSWD) in tota...
DH 97 is a selective MEL-1B-R (melatonin receptor) antagonist.
8-M-PDOT is a melatonin receptor agonist, with 20-fold selective for the MT2 (vs MT1) subtype (pKi = 8.23 and 8.95 at human recombinant MT1 and MT2 receptors re...
4-P-PDOT is a slelctive antagonist of MT2 melatonin receptor, and luzindole-an antagonist of both membrane receptors, on an oncostatic action of MLT. It display...
2-Phenylmelatonin is an antagonist of the MEL-1A-R, MEL-1B-R, MT3, observed to demonstrate mixed antagonist/agonist activity in systems with differential expres...
GR 135531 is a high affinity agonist of MT3 melatonin receptors, with low affinity for MT1 and MT2 melatonin receptors. GR 135531 can be used to discriminate be...
6-Chloromelatonin is a potent agonist of the melatonin receptors, which is active at nanomolar concentrations. It shows higher affinity for binding to hamster b...